Ana səhifə

Supplementary data Nickel-catalysed addition of organoboronates to 1,3-dienes


Yüklə 18.14 Kb.
tarix25.06.2016
ölçüsü18.14 Kb.

Supplementary Material (ESI) for Chemical Communications

This journal is © The Royal Society of Chemistry 2002



Supplementary data

Nickel-catalysed addition of organoboronates to 1,3-dienes
Eiji Shirakawa,* Go Takahashi, Teruhisa Tsuchimoto and Yusuke Kawakami
Graduate School of Materials Science, Japan Advanced Institute of Science and Technology, Asahidai, Tatsunokuchi, Ishikawa 923-1292, Japan. Fax: 81 761 51 1631; Tel: 81 761 51 1631; E-mail: shira@jaist.ac.jp
1H NMR and GC–MS data of hydroarylation and -alkenylation products



2,3-Dimethyl-3-(p-tolyl)-1-butene (3a). 1H NMR (300 MHz, CDCl3)  = 1.42 (s, 6 H), 1.54 (s, 3 H), 2.33 (s, 3 H), 4.73 (m, 1 H), 4.92 (m, 1 H), 7.05–7.13 (m, 2 H), 7.14–7.23 (m, 2 H); GC–MS m/z (relative intensity) 174 (M+, 28), 159 (100), 144 (13), 133 (31), 117 (14), 105 (33), 91 (21), 77 (14), 65 (7), 51 (5).



2,3-Dimethyl-1-(p-tolyl)-2-butene (4a). 1H NMR (300 MHz, CDCl3)  = 1.60 (s, 3 H), 1.74 (s, 3 H), 1.80 (s, 3 H), 2.33 (s, 3 H), 3.37 (s, 2 H), 7.00–7.11 (m, 4 H); GC–MS m/z (relative intensity) 174 (M+, 41), 159 (100), 144 (14), 131 (20), 117 (12), 105 (24), 91 (17), 77 (18), 67 (14), 51 (7).



2,3-Dimethyl-4-(p-tolyl)-1-butene (4’a). 1H NMR (300 MHz, CDCl3)  = 0.98 (d, J = 6.6 Hz, 3 H), 1.73 (s, 3 H), 2.32 (s, 3 H), 2.36–2.54 (m, 2 H), 2.70–2.81 (m, 1 H), 4.64–4.71 (m, 2 H), 7.00–7.12 (m, 4 H); GC–MS m/z (relative intensity) 174 (M+, 14), 159 (3), 141 (1), 128 (1), 115 (2), 105 (100), 91 (3), 77 (6), 69 (2), 51 (2).



2,3-Dimethyl-3-(4-methoxyphenyl)-1-butene (3b). 1H NMR (300 MHz, CDCl3)  = 1.40 (s, 6 H), 1.52 (m, 3 H), 3.79 (s, 3 H), 4.84–4.87 (m, 1 H), 4.94–4.97 (m, 1 H), 6.79–6.86 (m, 2 H), 7.18–7.24 (m, 2 H); GC–MS m/z (relative intensity) 190 (M+, 33), 175 (68), 160 (18), 149 (100), 128 (8), 121 (29), 109 (10), 91 (34), 77 (24), 65 (12), 51 (8).



2,3-Dimethyl-1-(4-methoxyphenyl)-2-butene (4b). 1H NMR (300 MHz, CDCl3)  = 1.58 (s, 3 H), 1.72 (s, 3 H), 1.78 (s, 3 H), 3.33 (s, 2 H), 3.78 (s, 3 H), 6.79–6.85 (m, 2 H), 7.03–7.10 (m, 2 H); GC–MS m/z (relative intensity) 190 (M+, 52), 175 (100), 160 (27), 147 (27), 128 (8), 121 (45), 108 (28), 91 (32), 77 (33), 67 (13), 51 (15).



2,3-Dimethyl-3-(4-trifluoromethylphenyl)-1-butene (3c). 1H NMR (300 MHz, CDCl3)  = 1.44 (s, 6 H), 1.50–1.52 (m, 3 H), 4.91–4.95 (m, 1 H), 5.00–5.02(m, 1 H), 7.38–7.44 (m, 2 H), 7.50–7.56 (m, 2 H); GC–MS m/z (relative intensity) 228 (M+, 6), 213 (41), 185 (11), 173 (5), 159 (100), 151 (8), 129 (9), 117(9), 109 (5), 91 (3), 77 (7), 57 (4), 51 (5).



2,3-Dimethyl-1-(4-trifluoromethylphenyl)-2-butene (4c). 1H NMR (300 MHz, CDCl3)  = 1.57–1.61 (m, 3H), 1.71–1.76 (m, 3 H), 1.76–1.80 (m, 3 H), 3.44 (s, 2 H), 7.21–7.28 (m, 2 H), 7.48–7.54 (m, 2 H); GC–MS m/z (relative intensity) 228 (M+, 59), 213 (100), 209 (10), 185 (39), 173 (7), 159 (44), 144 (6), 129 (10), 115 (10), 109 (13), 91 (7), 83 (6), 69 (25), 53 (12).



2,3-Dimethyl-3-(3-aminophenyl)-1-butene (3d). 1H NMR (300 MHz, CDCl3)  = 1.38 (s, 6 H), 1.52–1.54 (m, 3 H), 4.84–4.87 (m, 1 H), 4.97–4.50 (m, 1 H), 6.48–6.54 (m, 1 H), 6.62–6.65 (m, 1 H), 6.69–6.74 (m, 1 H), 7.04–7.01 (m, 1 H); GC–MS m/z (relative intensity) 175 (M+ 23), 160 (100), 145 (23), 130 (9), 118 (6), 106 (13), 93 (14), 77 (9), 65 (9), 51 (3).



2,3-Dimethyl-1-(3-aminophenyl)-2-butene (4d). 1H NMR (300 MHz, CDCl3)  = 1.57–1.61 (m, 3 H), 1.71–1.74 (m, 3 H), 1.76–1.79 (m, 3 H), 3.30 (s, 2 H), 6.45–6.54 (m, 2 H), 6.54–6.59 (m, 1 H), 7.02–7.09 (m, 1 H); GC–MS m/z (relative intensity) 175 (M+, 100), 160 (89), 145 (35), 132 (26), 118 (7), 106 (58), 93 (36), 77 (24), 65 (19), 51 (8).



2,3-Dimethyl-3-(2-naphthyl)-1-butene (3e). 1H NMR (300 MHz, CDCl3)  = 1.52 (s, 6 H), 1.52–1.54 (m, 3 H), 4.92–4.96 (m, 1 H), 5.04–5.06 (m, 1 H), 7.38–7.49 (m, 3 H), 7.72–7.84 (m, 4 H); GC–MS m/z (relative intensity) 210 (M+, 54), 195 (100), 180 (22), 165 (55), 141 (47), 128 (25), 115 (16), 102 (5), 89 (23), 76 (15), 63 89), 51 (9).



2,3-Dimethyl-1-(2-naphthyl)-2-butene (4e). 1H NMR (300 MHz, CDCl3)  = 1.60–1.65 (m, 3 H), 1.74–1.79 (m, 3 H), 1.82–1.86 (m, 3 H), 3.55 (s, 2 H), 7.26–7.32 (m, 1 H), 7.35–7.49 (m, 2 H), 7.54–7.58 (m, 1 H), 7.66-7.85 (m, 3 H); GC–MS m/z (relative intensity) 210 (M+, 76), 195 (100), 180 (24), 165 (53), 141 (45), 128 (45), 115 (42), 102 (3), 89 (16), 82 (30), 67 (13), 51 (7).



2,3-Dimethyl-3-(3-thienyl)-1-butene (3f). 1H NMR (300 MHz, CDCl3)  = 1.43 (s, 6 H), 1.55–1.59 (s, 3 H), 4.79–4.83 (m, 1 H), 4.87–4.90 (m, 1 H), 6.92 (dd, J = 4.8, 1.5 Hz, 1 H), 6.97 (dd, J = 3.0, 1.5 Hz, 1 H), 7.20–7.24 (m, 1 H); GC–MS m/z (relative intensity) 166 (M+, 45), 151 (100), 135 (5), 125 (32), 105 (6), 97 (49), 77 (5), 65 (6), 51 (5).



2,3-Dimethyl-1-(3-thienyl)-2-butene (4f). 1H NMR (300 MHz, CDCl3)  = 1.62–1.65 (m, 3 H), 1.69–1.73 (m, 3 H), 1.75–1.78 (s, 3 H), 3.36 (s, 3 H), 6.86–6.90 (m, 2 H), 7.20–7.24 (m, 1 H); GC–MS m/z (relative intensity) 166 (M+, 95), 151 (100), 136 (5), 117 (13), 105 (13), 97 (77), 82 (11), 67 (24), 53 (17).



(E)-2,3,3-Trimethyl-1,4-undecadiene (3g). 1H NMR (300 MHz, CDCl3)  = 0.84–0.92 (m, 3 H), 1.12 (s, 6 H), 1.21–1.40 (m, 8 H), 1.67–1.70 (m, 3 H), 1.93–2.03 (m, 2 H), 4.70–4.73 (m, 1 H), 4.75–4.78 (m, 1 H), 5.28–5.43 (m, 2 H); GC–MS m/z (relative intensity) 194 (M+, 3), 179 (7), 151 (5), 137 (3), 123 (15), 109 (100, 95 (84), 81 (85), 67 (80), 55 (52).



(E)-2,3-Dimethyl-2,5-dodecadiene (4g). 1H NMR (300 MHz, CDCl3)  = 0.84–0.92 (m, 3 H), 1.21–1.40 (m, 8 H), 1.58–1.63 (m, 3 H), 1.64–1.68 (m, 6 H), 1.93–2.04 (m, 2 H), 2.69 (d, J = 5.7 Hz, 2 H), 5.25–5.45 (m, 2 H); GC–MS m/z (relative intensity) 194 (M+, 12), 151 (3), 137 (1), 123 (11), 109 (30), 95 (68), 81 (100), 67 (59), 55 (39).



(E)-1-Phenyl-3,3,4-trimethyl-1,4-pentadiene (3h). 1H NMR (300 MHz, CDCl3)  = 1.26 (s, 6 H), 1.73–1.77 (m, 3 H), 4.79–4.83 (m, 1 H), 4.85–4.87 (m, 1 H), 6.20 (d, J = 16.2 Hz, 1 H), 6.35 (d, J = 16.2 Hz, 1 H), 7.15–7.40 (m, 5 H); GC–MS m/z (relative intensity) 186 (M+, 28), 171 (100), 156 (28), 143 (100), 129 (41), 115 (25), 105 (11), 91 (85), 77 (26), 65 (10), 51 (13).



(E)-4,5-Dimethyl-1-phenyl-1,4-hexadiene (4h). 1H NMR (300 MHz, CDCl3)  = 1.62–1.76 (m, 9 H), 2.92 (d, J = 6.6 Hz, 2 H), 6.16 (dt, J = 15.6, 6.6 Hz, 1 H), 6.30–6.40 (m, 1 H), 7.16–7.40 (m, 5 H); GC–MS m/z (relative intensity) 186 (M+, 59), 171 (73), 156 (16), 143 (90), 129 (41), 115 (38), 104 (20), 91 (100), 77 (24), 67 (30), 55 (32).



(Z)-2,3-Diphenyl-1-(p-tolyl)-2-butene ((Z)-6a). 1H NMR (300 MHz, CDCl3)  = 1.91 (s, 3 H), 2.24 (s, 3 H), 3.58 (s, 2 H), 6.75–7.00 (m, 4 H), 7.06–7.44 (m, 10 H); GC–MS m/z (relative intensity) 298 (M+, 72), 283 (48), 220 (22), 205 (63), 191 (52), 178 (50), 165 (27), 152 (14), 128 (17), 115 (77), 105 (39), 91 (100), 77 (54), 65 (21), 51 (23).



(E)-2,3-Diphenyl-1-(p-tolyl)-2-butene ((E)-6a). 1H NMR (300 MHz, CDCl3)  = 2.23 (s, 3 H), 2.30 (s, 3 H), 3.91 (s, 2 H), 6.87–7.17 (m, 14 H).



(E)-3-Methyl-1,3,4-triphenyl-1,4-pentadiene (5b). 1H NMR (300 MHz, CDCl3)  = 1.60 (s, 3 H), 5.33 (d, J = 1.2 Hz, 1 H), 5.37 (d, J = 1.2 Hz, 1 H), 6.16 (d, J = 16.2 Hz, 1 H), 6.64 (d, J = 16.2 Hz, 1 H), 6.89–7.00 (m, 2 H), 7.08–7.52 (m, 13 H).



(1E,4Z)-1,4,5-Triphenyl-1,4-hexadiene ((Z)-6b). 1H NMR (300 MHz, CDCl3)  = 1.89 (s, 3 H), 3.13 (d, J = 6.3 Hz, 2 H), 6.02 (dt, J = 16.2, 6.3 Hz, 1 H), 6.14 (d, J = 16.2 Hz, 1 H), 7.13–7.42 (m, 15 H); GC–MS m/z (relative intensity) 310 (M+, 14), 295 (5), 232 (4), 219 (69), 204 (30), 191 (16), 178 (23), 165 (12), 152 (6), 128 (5), 115 (31), 105 (8), 91 (100), 77 (14), 65 (7), 51 (7).



(1E,4E)-1,4,5-Triphenyl-1,4-hexadiene ((E)-6b). This compound, produced only in a small amount, was not isolated and could not be characterized by 1H NMR. Because the GC–MS analysis implies that the compound is an isomer of 5b and (Z)-6b, we characterized this as (E)-6b. GC–MS m/z (relative intensity) 310 (M+, 13), 296 (2), 281 (3), 253 (3), 233 (2), 219 (73), 204 (30), 191 (14), 178 (18), 165 (12), 152 (8), 128 (5), 115 (36), 105 (6), 91 (100), 77 (20), 65 (9), 51 (9).

S


Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©atelim.com 2016
rəhbərliyinə müraciət